Literature DB >> 29560698

Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.

Yilmaz Bilgic1, Cengiz Yilmaz1, Yasir Furkan Cagin1, Yahya Atayan1, Nese Karadag2, Murat Muhsin Muhip Harputluoglu1.   

Abstract

INTRODUCTION: Drug induced acute toxic hepatitis can be idiosyncratic. Albendazole, a widely used broad spectrum antiparasitic drug is generally accepted as a safe drug. It may cause asymptomatic transient liver enzyme abnormalities but acute toxic hepatitis is very rare. Case Report : Herein, we present the case of 47 year old woman with recurrent acute toxic hepatitis after a single intake of albendazole in 2010 and 2014. The patient was presented with symptoms and findings of anorexia, vomiting and jaundice. For diagnosis, other acute hepatitis etiologies were excluded. Roussel Uclaf Causality Assessment Method (RUCAM) score was calculated and found to be 10, which meant highly probable drug hepatotoxicity. Within 2 months, all pathological findings came to normal. RESULT: There are a few reported cases of albendazole induced toxic hepatitis, but at adults, there is no known recurrent acute toxic hepatitis due to albendazole at this certainty according to RUCAM score.
CONCLUSION: Physicians should be aware of this rare and potentially fatal adverse effect of albendazole. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  albendazole; hepatitis; recurrent; toxic

Mesh:

Substances:

Year:  2017        PMID: 29560698

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  4 in total

Review 1.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

2.  Isolated splenic cystic echinococcosis and albendazole hepatotoxicity.

Authors:  Nikolaos Moussas; Sotirios Adamidis; Nikolaos Adamidis; Charalabos Stratopoulos; Panagiotis Gargalianos-Kakolyris
Journal:  IDCases       Date:  2022-04-12

3.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

4.  Evaluation of albendazole efficiency and complications in patients with pulmonary hydatid cyst.

Authors:  Yener Aydin; Ali Bilal Ulas; Ilker Ince; Asli Kalin; Fatma Kesmez Can; Betul Gundogdu; Kamber Kasali; Bugra Kerget; Yasemin Ogul; Atilla Eroglu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.